xeljanz comprimé
pfizer canada ulc - tofacitinib (citrate de tofacitinib) - comprimé - 5mg - tofacitinib (citrate de tofacitinib) 5mg - disease-modifying antirheumatic agents
mabcampath solution
sanofi genzyme, a division of sanofi-aventis canada inc - alemtuzumab - solution - 30mg - alemtuzumab 30mg - antineoplastic agents
xeljanz xr comprimé (à libération prolongée)
pfizer canada ulc - tofacitinib (citrate de tofacitinib) - comprimé (à libération prolongée) - 11mg - tofacitinib (citrate de tofacitinib) 11mg - disease-modifying antirheumatic agents
mabcampath solution
genzyme corporation - alemtuzumab - solution - 10mg - alemtuzumab 10mg - antineoplastic agents
xeljanz comprimé
pfizer canada ulc - tofacitinib (citrate de tofacitinib) - comprimé - 10mg - tofacitinib (citrate de tofacitinib) 10mg - disease-modifying antirheumatic agents
pms-tofacitinib comprimé
pharmascience inc - tofacitinib (citrate de tofacitinib) - comprimé - 5mg - tofacitinib (citrate de tofacitinib) 5mg
taro-tofacitinib comprimé
taro pharmaceuticals inc - tofacitinib (citrate de tofacitinib) - comprimé - 5mg - tofacitinib (citrate de tofacitinib) 5mg
taro-tofacitinib comprimé
taro pharmaceuticals inc - tofacitinib (citrate de tofacitinib) - comprimé - 10mg - tofacitinib (citrate de tofacitinib) 10mg
jamp tofacitinib comprimé
jamp pharma corporation - tofacitinib (citrate de tofacitinib) - comprimé - 5mg - tofacitinib (citrate de tofacitinib) 5mg
revlimid capsule
bristol-myers squibb canada - lénalidomide - capsule - 20mg - lénalidomide 20mg - antineoplastic agents